Genetic Networks is a pharmaceutical research and development company based in Florida. According to federal lobbying filings, it engaged a private lobbying firm (Albertine Enterprises) but reported no lobbying spending across three filings. The filings identify it as a biopharma in-house client; they do not provide specific policy goals or targets for its lobbying.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
This client has not yet disclosed issue activity in the available filings.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
No lobbyists are disclosed for this client yet.
The latest disclosures for this client.
ALBERTINE ENTERPRISES, INC.
3TYALBERTINE ENTERPRISES, INC.
Q2YALBERTINE ENTERPRISES, INC.
The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
This client's filings do not yet disclose named government entities.